Switch to:
More From Other Websites
Myriad Genetics downgraded by BofA/Merrill Jul 29 2016
Myriad to Announce Fiscal Fourth-Quarter 2016 Financial Results on August 9 Jul 26 2016
Myriad to Announce Fiscal Fourth-Quarter 2016 Financial Results on August 9 Jul 26 2016
Myriad Genetics, Inc. breached its 50 day moving average in a Bullish Manner : MYGN-US : July 26,... Jul 26 2016
Myriad Announces Positive Results for an EndoPredict® Clinical Study Published in the Journal of... Jul 11 2016
Myriad Announces Positive Results for an EndoPredict® Clinical Study Published in the Journal of... Jul 11 2016
Myriad Genetics myChoice Cancer Test Findings Encourage Jul 01 2016
Myriad Genetics: Study Data Drives Growth, Competition Rife Jul 01 2016
MYRIAD GENETICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jun 30 2016
MYRIAD GENETICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jun 29 2016
Myriad's myChoice® HRD Test Successfully Identifies Patients that Meet Primary Endpoint in TESARO's... Jun 29 2016
Myriad’s myChoice® HRD Test Successfully Identifies Patients that Meet Primary Endpoint in... Jun 29 2016
Crescendo Bioscience Announces that New Data on Vectra® DA Will Be Presented at the European League... Jun 10 2016
MYRIAD GENETICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 07 2016
Myriad Gets $200 Million More For Share Repurchase Program Jun 07 2016
Myraid Genetics increases share buyback program by $200 million Jun 07 2016
Myriad Board Approves $200 Million Increase in Share Repurchase Program Jun 07 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK